Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Interest Coverage Ratio (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Interest Coverage Ratio readings, the most recent being 4.06 for Q1 2026.

  • On a quarterly basis, Interest Coverage Ratio fell 110.64% to 4.06 in Q1 2026 year-over-year; TTM through Mar 2026 was 9.79, a 227.57% decrease, with the full-year FY2025 number at 1.81, up 110.02% from a year prior.
  • Interest Coverage Ratio hit 4.06 in Q1 2026 for Atara Biotherapeutics, up from 35.3 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 38.15 in Q1 2025 to a low of 22055.0 in Q1 2022.
  • Median Interest Coverage Ratio over the past 5 years was 35.3 (2025), compared with a mean of 1407.08.
  • The widest YoY moves for Interest Coverage Ratio: up 240.78% in 2025, down 194.15% in 2025.
  • Atara Biotherapeutics' Interest Coverage Ratio stood at 645.63 in 2022, then surged by 92.1% to 50.99 in 2023, then surged by 76.47% to 12.0 in 2024, then crashed by 194.15% to 35.3 in 2025, then soared by 88.5% to 4.06 in 2026.
  • The last three reported values for Interest Coverage Ratio were 4.06 (Q1 2026), 35.3 (Q4 2025), and 3.93 (Q3 2025) per Business Quant data.